Operating Lease, Right-of-Use Asset of Yubo International Biotech Ltd from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Yubo International Biotech Ltd quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Yubo International Biotech Ltd Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $138,604, a 76% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Yubo International Biotech Ltd Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $138,604 -$440,840 -76% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $184,943 -$314,069 -63% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $231,407 -$60,192 -21% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $478,765 +$86,852 +22% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $579,444 +$88,663 +18% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $499,012 -$61,593 -11% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $291,599 -$375,447 -56% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $391,913 -$398,586 -50% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $490,781 -$1,713,228 -78% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $560,605 -$1,835,919 -77% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $667,046 -$2,105,730 -76% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $790,499 -$1,903,485 -71% 31 Dec 2022 10-K 12 Apr 2024 2023 FY
Q3 2022 $2,204,009 -$138,729 -5.9% 30 Sep 2022 10-Q 16 Nov 2022 2022 Q3
Q2 2022 $2,396,524 +$345,539 +17% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $2,772,776 +$830,425 +43% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $2,693,984 +$2,378,777 +755% 31 Dec 2021 10-K 14 Apr 2023 2022 FY
Q3 2021 $2,342,738 30 Sep 2021 10-Q 15 Nov 2021 2021 Q2
Q2 2021 $2,050,985 30 Jun 2021 10-Q 20 Aug 2021 2021 Q2
Q1 2021 $1,942,351 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 $315,207 31 Dec 2020 10-K 15 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.